why choose us

300×250 Ad Slot

Research Article: Outcomes of Antineoplastic Immunotherapy at a Large Healthcare Organization: Impact of Provider, Race and Socioeconomic Status

Date Published: 2023-09-01

Introduction:
Since the United States (US) Food and Drug Administration’s (FDA) approval of ipilimumab in , the use of immune checkpoint inhibitors (ICI) has revolutionized the treatment paradigm of most advanced solid tumors. , With indications and available agents on the market, medical oncologists are able to extend the survival of patients with solid tumors beyond any historical perspective. , Immune-related adverse events (irAEs) occur in –% of patients treated with ICIs, which may affect any organ system with variable…

Read more

300×250 Ad Slot